Gutic B, Bozanovic T, Mandic A, Dugalic S, Todorovic J, Dugalic MG, et al. Preliminary outcomes of five-year survival for ovarian malignancies in profiled serbian oncology centre. Clinics (Sao Paulo, Brazil). 2023. https://doi.org/10.1016/j.clinsp.2023.100204.

Article  PubMed  PubMed Central  Google Scholar 

Arora T, Mullangi S, Vadakekut ES, Lekkala MR. Epithelial Ovarian Cancer. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024.

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020. https://doi.org/10.3322/caac.21590.

Article  PubMed  Google Scholar 

Feeney L, Harley IJ, McCluggage WG, Mullan PB, Beirne JP. Liquid biopsy in ovarian cancer: catching the silent killer before it strikes. World J Clin Oncol. 2020. https://doi.org/10.5306/wjco.v11.i11.868.

Article  PubMed  PubMed Central  Google Scholar 

Łukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanisławek A. Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-an updated review. Cancers. 2021. https://doi.org/10.3390/cancers13174287.

Article  PubMed  PubMed Central  Google Scholar 

Ali AT, Al-Ani O, Al-Ani F. Epidemiology and risk factors for ovarian cancer. Przeglad Menopauzalny Menopause Rev. 2023. https://doi.org/10.5114/pm.2023.128661.

Article  Google Scholar 

Wright JD, Chen L, Tergas AI, Patankar S, Burke WM, Hou JY, et al. Trends in relative survival for ovarian cancer from 1975 to 2011. Obstet Gynecol. 2015. https://doi.org/10.1097/aog.0000000000000854.

Article  PubMed  PubMed Central  Google Scholar 

Shen F, Chen S, Gao Y, Dai X, Chen Qi. The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women. Oncotarget. 2017;8(46):80589–94. https://doi.org/10.18632/oncotarget.20384.

Article  PubMed  PubMed Central  Google Scholar 

Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018. https://doi.org/10.3322/caac.21456.

Article  PubMed  PubMed Central  Google Scholar 

Momenimovahed Z, Tiznobaik A, Taheri S, Salehiniya H. Ovarian cancer in the world: epidemiology and risk factors. Int J Women’s Health. 2019. https://doi.org/10.2147/ijwh.s197604.

Article  Google Scholar 

Zheng L, Cui C, Shi O, Lu X, Li YK, Wang W, et al. Incidence and mortality of ovarian cancer at the global, regional, and national levels, 1990–2017. Gynecol Oncol. 2020. https://doi.org/10.1016/j.ygyno.2020.07.008.

Article  PubMed  PubMed Central  Google Scholar 

Rahmani K, Moradi-Lakeh M, Mansori K, Bidokhti F, Asadi-Lari M. Global inequalities in incidence and mortality of ovarian cancer and associated factors: an ecological study. Alzheimers Park Res Ther. 2018;1:1001.

Google Scholar 

Collaborators GDaI. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet (London, England). 2020; https://doi.org/10.1016/s0140-6736(20)30925-9

Collaborators GD 2020 Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet (London, England). https://doi.org/10.1016/s0140-6736(20)30977-6.

Fantom N, Serajuddin U. The World Bank's classification of countries by income. The World Bank; 2016, http://hdl.handle.net/10986/23628.

Whitehead SJ, Ali S. Health outcomes in economic evaluation: the QALY and utilities. Br Med Bull. 2010. https://doi.org/10.1093/bmb/ldq033.

Article  PubMed  Google Scholar 

Mazidimoradi A, Momenimovahed Z, Khani Y, Rezaei Shahrabi A, Allahqoli L, Salehiniya H. Global patterns and temporal trends in ovarian cancer morbidity, mortality, and burden from 1990 to 2019. Oncologie. 2023. https://doi.org/10.1186/s12889-022-13861-y.

Article  Google Scholar 

Zhou Z, Wang X, Ren X, Zhou L, Wang N, Kang H. disease burden and attributable risk factors of ovarian cancer from 1990 to 2017: findings from the global burden of disease study 2017. Front Public Health. 2021. https://doi.org/10.3389/fpubh.2021.619581.

Article  PubMed  PubMed Central  Google Scholar 

Yang D, Huang H, Ruan T, Yang H, Hu J, Xu S, et al. Global, regional, and national burden of ovarian cancer and the attributable risk factors in all 194 countries and territories during 2007–2017: a systematic analysis of the global burden of disease study 2017. J Obstet Gynaecol Res. 2021. https://doi.org/10.1111/jog.15019.

Article  PubMed  PubMed Central  Google Scholar 

Kim EJ, Jung SW, Kim YE, Go DS, Yoon SJ. Assessing the impact of aging on burden of disease. Iran J Public Health. 2018;47(Suppl 1):33–8.

PubMed  PubMed Central  Google Scholar 

Wang J, Lv H, Xue Z, Wang L, Bai Z. Temporal trends of common female malignances on breast, cervical, and ovarian cancer mortality in japan, republic of korea, and singapore: application of the age-period-cohort model. BioMed Res Int. 2018. https://doi.org/10.1155/2018/5307459.

Article  PubMed  PubMed Central  Google Scholar 

Pulumati A, Pulumati A, Dwarakanath BS, Verma A, Papineni RVL. Technological advancements in cancer diagnostics: improvements and limitations. Cancer Rep (Hoboken, NJ). 2023. https://doi.org/10.1002/cnr2.1764.

Article  Google Scholar 

Huang J, Chan WC, Ngai CH, Lok V, Zhang L, Lucero-Prisno DE 3rd, et al. Worldwide burden, risk factors, and temporal trends of ovarian cancer: a global study. Cancers. 2022. https://doi.org/10.3390/cancers14092230.

Article  PubMed  PubMed Central  Google Scholar 

Zhang Y, Luo G, Li M, Guo P, Xiao Y, Ji H, et al. Global patterns and trends in ovarian cancer incidence: age, period and birth cohort analysis. BMC Cancer. 2019. https://doi.org/10.1186/s12885-019-6139-6.

Article  PubMed  PubMed Central  Google Scholar 

Zhang S, Cheng C, Lin Z, Xiao L, Su X, Zheng L, et al. The global burden and associated factors of ovarian cancer in 1990–2019: findings from the Global Burden of disease Study 2019. BMC Public Health. 2022. https://doi.org/10.1186/s12889-022-13861-y.

Article  PubMed  PubMed Central  Google Scholar 

Beniwal S, Lamo P, Kaushik A, Lorenzo-Villegas D, Liu Y, MohanaSundaram ArunSundar. current status and emerging trends in colorectal cancer screening and diagnostics. Biosensors. 2023;13(10):926. https://doi.org/10.3390/bios13100926.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fullman N, Yearwood J, Abay SM, Abbafati C, Abd-Allah F, Abdela J, et al. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. The Lancet. 2018;391:2236. https://doi.org/10.1016/S0140-6736(18)30994-2.

Article  Google Scholar 

Reid BM, Permuth JB, Sellers TA. Epidemiology of ovarian cancer: a review. Cancer Biol Med. 2017;14:9. https://doi.org/10.20892/j.issn.2095-3941.2016.0084.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Go D-S, Kim Y-E, Yoon S-J. Subnational Burden of Disease According to the Sociodemographic Index in South Korea. Int J Environ Res Public Health. 2020;17(16):5788. https://doi.org/10.3390/ijerph17165788.

Article  PubMed  PubMed Central  Google Scholar 

Ranabhat CL, Jakovljevic M, Dhimal M, Kim C-B. Structural Factors Responsible for Universal Health Coverage in Low- and Middle-Income Countries: Results From 118 Countries. Front Public Health. 2020. https://doi.org/10.3389/fpubh.2019.00414.

Article  PubMed  PubMed Central  Google Scholar 

Siminiak N, Czepczyński R, Zaborowski MP, Iżycki D. Immunotherapy in Ovarian Cancer. Arch Immunol Ther Exp. 2022. https://doi.org/10.1007/s00005-022-00655-8.

Article  Google Scholar 

Yang C, Xia B-R, Zhang Z-C, Zhang Y-J, Lou Ge, Jin W-L. Immunotherapy for ovarian cancer: adjuvant, combination, and neoadjuvant. Front Immunol. 2020. https://doi.org/10.3389/fimmu.2020.577869.

Article  PubMed  PubMed Central  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

Article  CAS  Google Scholar 

Wojtyła C, Bertuccio P, Giermaziak W, Santucci C, Odone A, Ciebiera M, Negri E, Wojtyła A, La Vecchia C. European trends in ovarian cancer mortality, 1990–2020 and predictions to 2025. Eur J Cancer. 2023;194:113350.